These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1488427

  • 1. [Hypereosinophilic syndrome in a myeloproliferative variety. Success after 18 month treatment with interferon alpha].
    Dine G, Najman A, Brahimi S, Culioli B, Abid A, Dupoirieux J.
    Presse Med; 1992 Nov 07; 21(37):1776. PubMed ID: 1488427
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Eosinophilic myeloproliferative disorders.
    Klion AD.
    Hematology Am Soc Hematol Educ Program; 2011 Nov 07; 2011():257-63. PubMed ID: 22160043
    [Abstract] [Full Text] [Related]

  • 6. [Hypereosinophilia syndrome. Apropos of 2 cases and literature review].
    Straetmans N, Ferrant A, Martiat P, Sokal G, Michaux JL.
    Acta Clin Belg; 1992 Nov 07; 47(2):90-9. PubMed ID: 1321541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Disorders with eosinophilia, treatment of hypereosinophilic syndrome].
    Borbényi Z.
    Orv Hetil; 2005 May 01; 146(18 Suppl 1):911-6. PubMed ID: 15921304
    [Abstract] [Full Text] [Related]

  • 10. Alfa-interferon in a case of hypereosinophilic syndrome.
    Murphy PT, Fennelly DF, Stuart M, O'Donnell JR.
    Br J Haematol; 1990 Aug 01; 75(4):619-20. PubMed ID: 2207015
    [No Abstract] [Full Text] [Related]

  • 11. [Alfa-2b interferon in the treatment of thrombocytosis associated to chronic non leukemic myeloproliferative syndromes].
    Petit J, Callís M, Domingo Albós A, Fernández de Sevilla A, Besses C, Martí JM.
    Med Clin (Barc); 1993 Nov 13; 101(16):601-3. PubMed ID: 8271861
    [Abstract] [Full Text] [Related]

  • 12. Disappearance of spontaneous erythroid colonies in patients with myeloproliferative disorders treated by alpha-interferon.
    Teofili L, de Stefano V, Iovino MS, Voso MT, Tartaglione R, Bizzi B, Leone G.
    Br J Haematol; 1992 Jun 13; 81(2):310-1. PubMed ID: 1643032
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of thrombocytosis in myeloproliferative syndromes using recombinant interferon-alpha-2a].
    Tichelli A, Gratwohl A, Delacrétaz F, Dazzi H, Stebler C, Wernli M, Holdener EE, Nissen C, Speck B.
    Schweiz Med Wochenschr; 1989 Sep 30; 119(39):1347-52. PubMed ID: 2799342
    [Abstract] [Full Text] [Related]

  • 17. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T.
    Acta Haematol Pol; 1992 Sep 30; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [Abstract] [Full Text] [Related]

  • 18. [Interferon-alpha in the treatment of myeloproliferative syndromes].
    Ballarino P, Castello G, Lerza R.
    Recenti Prog Med; 1994 Nov 30; 85(11):546-50. PubMed ID: 7855389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.